Industry News

The following is information provided by IXINITY. Read the full statement here.

“The health and safety of individuals who rely on our products, their caregivers and community members, healthcare professionals, and our own team is of upmost importance to Medexus Pharma, the company behind IXINITY.聽 We want to reassure the community that we currently do not see any impact to our ability to supply the US market with IXINITY, coagulation factor IX (recombinant).”

Read the full statement here.

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.